Stenke L, Sjölinder M, Miale T D, Lindgren J A
Division of Physiological Chemistry II, Department of Medical Biochemistry and Biophysics, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden.
Br J Haematol. 1998 Jun;101(4):728-36. doi: 10.1046/j.1365-2141.1998.00752.x.
Leukotrienes (LT) are inflammatory mediators which can also exert regulatory effects on human myelopoiesis. We have studied the LT-producing capacity of freshly isolated leucocyte suspensions (containing blast cells in variable proportions) from 41 patients with acute myeloid leukaemia (AML) or chronic myeloid leukaemia (CML) in blast crisis (CMLbc) at diagnosis or relapse/resistant disease. Leucocyte suspensions from 19/29 AML patients (66%), and 2/12 CMLbc patients (17%; P = 0.012) demonstrated deficient capacity to synthesize LT from endogenous substrate after ionophore A23187 stimulation. Thus, these cells produced < 8 pmol LTB4+LTC4/10(6) cells (< 20% of mean LT formation in leucocyte suspensions from 18 healthy subjects). Addition of exogenous arachidonic acid did not normalize the LT synthesis in poor-producing cell suspensions. Purified, morphologically mature granulocytes from two AML patients also failed to produce normal amounts of LT. In leucocyte suspensions from the remaining 20 AML/CMLbc patients A23187 provoked LT biosynthesis, with markedly increased production of LTC4, but decreased LTB4 formation. Furthermore, elevated conversion of exogenous LTA4 to LTC4 was noted in the patient samples, independent of their capacity to produce LT after A23187 stimulation. The percentage of blast cells in patient white blood cell differential counts correlated inversely with ionophore-induced LT synthesis, but positively with the conversion of exogenous LTA4 to LTC4. The results suggest elevated LTC4 synthase activity and suppressed 5-lipoxygenase activity as novel enzymatic features of myeloid leukaemia patients with immature phenotype.
白三烯(LT)是炎症介质,也可对人类骨髓生成发挥调节作用。我们研究了41例急性髓系白血病(AML)或处于急变期的慢性髓系白血病(CMLbc)患者在诊断时或复发/耐药疾病时新鲜分离的白细胞悬液(含有比例各异的原始细胞)产生LT的能力。来自19/29例AML患者(66%)和2/12例CMLbc患者(17%;P = 0.012)的白细胞悬液在离子载体A23187刺激后,显示出从内源性底物合成LT的能力不足。因此,这些细胞产生的白三烯B4(LTB4)和白三烯C4(LTC4)<8 pmol/10⁶细胞(<18名健康受试者白细胞悬液中LT平均生成量的20%)。添加外源性花生四烯酸并不能使低产细胞悬液中的LT合成恢复正常。来自两名AML患者的纯化的、形态成熟的粒细胞也未能产生正常量的LT。在其余20例AML/CMLbc患者的白细胞悬液中,A23187刺激引发了LT生物合成,LTC4的生成显著增加,但LTB4的生成减少。此外,在患者样本中观察到外源性白三烯A4(LTA4)向LTC4的转化增加,这与它们在A23187刺激后产生LT的能力无关。患者白细胞分类计数中原始细胞的百分比与离子载体诱导的LT合成呈负相关,但与外源性LTA4向LTC4的转化呈正相关。结果表明,LTC4合酶活性升高和5-脂氧合酶活性受抑制是具有未成熟表型的髓系白血病患者的新酶学特征。